Cargando…

The role of aspirin in the prevention of ovarian, endometrial and cervical cancers

Drug repurposing is the application of an existing licenced drug for a new indication and potentially provides a faster and cheaper approach to developing new anti-cancer agents. Gynaecological cancers contribute significantly to the global cancer burden, highlighting the need for low cost, widely a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joharatnam-Hogan, Nalinie, Cafferty, Fay H, Macnair, Archie, Ring, Alistair, Langley, Ruth E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543116/ https://www.ncbi.nlm.nih.gov/pubmed/33019903 http://dx.doi.org/10.1177/1745506520961710

Ejemplares similares

Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2021)

Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?
por: Coyle, Christopher, et al.
Publicado: (2016)

COVID-19 cancer conundrum—evidence driving decisions or the lack of it?
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020)

ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
por: Coyle, Christopher, et al.
Publicado: (2016)

Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2023)

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
por: Langley, R E, et al.
Publicado: (2011)

Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial
por: South, Annabelle, et al.
Publicado: (2021)

Accessing routinely collected health data to improve clinical trials: recent experience of access
por: Macnair, Archie, et al.
Publicado: (2021)

Aspirin and endometrial cancer risk
por: Brasky, Theodore M., et al.
Publicado: (2016)

Clinical evidence for the use of aspirin in the treatment of cancer
por: Langley, Ruth E
Publicado: (2013)

Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes—The University College London Hospital (UCLH) Experience
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020)

The Role of Selenium and Manganese in the Formation, Diagnosis and Treatment of Cervical, Endometrial and Ovarian Cancer
por: Golara, Anna, et al.
Publicado: (2023)

Fertility preservation in women with cervical, endometrial or ovarian cancers
por: Feichtinger, Michael, et al.
Publicado: (2016)

Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010
por: Lim, Myong Cheol, et al.
Publicado: (2013)

Circular RNAs: Novel biomarkers for cervical, ovarian and endometrial cancer
por: Shi, Yuchuan, et al.
Publicado: (2020)

REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers
por: Merrick, Sophie, et al.
Publicado: (2023)

A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis
por: Joharatnam, Nalinie, et al.
Publicado: (2015)

Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015
por: Lim, Myong Cheol, et al.
Publicado: (2018)

Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization
por: Hurst, Bradley S, et al.
Publicado: (2005)

The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis
por: Smith, Tom, et al.
Publicado: (2014)

Aspirin and prostate cancer prevention
por: Vidal, Adriana C., et al.
Publicado: (2015)

The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
por: Stępień, Sebastian, et al.
Publicado: (2023)

Aspirin and Its Potential Preventive Role in Cancer: An Umbrella Review
por: Song, Yongxi, et al.
Publicado: (2020)

Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis
por: McWilliams, Daniel F., et al.
Publicado: (2018)

Aspirin use and endometrial cancer risk: a meta-analysis and systematic review
por: Wang, Yang, et al.
Publicado: (2020)

Molecular targets of aspirin and cancer prevention
por: Alfonso, L, et al.
Publicado: (2014)

The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings
por: Chang, Cheng-Chang, et al.
Publicado: (2018)

Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey
por: Luyckx, Annemie, et al.
Publicado: (2020)

Aspirin for Prevention of Preeclampsia
por: Atallah, A., et al.
Publicado: (2017)

Imaging of endometrial and cervical cancer
por: Patel, Shilpa, et al.
Publicado: (2010)

Radiomics in cervical and endometrial cancer
por: Manganaro, Lucia, et al.
Publicado: (2021)

Aspirin in the 21st century—common mechanisms of disease and their modulation by aspirin: a report from the 2015 scientific conference of the international aspirin foundation, 28 August, London, UK
por: Smith, Tom, et al.
Publicado: (2015)

The role of low-dose aspirin in the prevention of pre-eclampsia
por: Akhigbe, R. E.
Publicado: (2014)

Effects of methylenetetrahydrofolate reductase single-nucleotide polymorphisms on breast, cervical, ovarian, and endometrial cancer susceptibilities
por: Wang, Zheng, et al.
Publicado: (2021)

New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review
por: Gheorghe, Adelina Silvana, et al.
Publicado: (2022)

The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
por: Ha, Hyeong In, et al.
Publicado: (2021)

Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management
por: Beavis, Anna L, et al.
Publicado: (2016)

Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020)

Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian origin
por: Lin, Douglas I., et al.
Publicado: (2020)

Site staff perspectives on communicating trial results to participants: Cost and feasibility results from the Show RESPECT cluster randomised, factorial, mixed-methods trial
por: South, Annabelle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d99vpcs31r1tq3at6blsj78td7